Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Iran reviewing US proposal to end war although key demands remain unaddressed
Israeli strikes kill five, injure son of Hamas chief in Gaza
Israel strikes Beirut for first time since ceasefire
US and Iran closing in on memorandum to end war, sources say
